4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-23-006195
Options or other derivatives
- Chief Financial Officer acquired 169,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2023-02-01 | Grant or award · Stock Option (right to buy) | +145,000 | 145,000 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2023-02-01 | Grant or award · Restricted Stock Unit | +24,000 | 24,000 | D | ||
Loading xslF345X03/doc4.xml…